tropicamide has been researched along with Retrolental Fibroplasia in 18 studies
Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe and compare the effects of pupil dilation between Mydrin-P and compound tropicamide in the screening of retinopathy of prematurity." | 7.80 | Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity. ( Lu, Y; Luo, S; Wan, Z; Ye, Z; Yin, X, 2014) |
| "A comprehensive literature search was performed in PubMed, Cochrane library, Trip database, and Scopus, using the key words: "mydriasis", "techniques", "mydriatics", "dilating drops", "retinopathy of prematurity", "ROP", "phenylephrine", "cyclopentolate", "tropicamide", "smaller mydriatic drops", "reduction in drop size" to February 2019." | 5.05 | Alternative mydriasis techniques for retinopathy of prematurity screening. ( Kokkali, S; Lithoxopoulou, M; Mataftsi, A; Prousali, E; Seliniotaki, AK; Soubasi, V; Ziakas, N, 2020) |
| "5% tropicamide and 5% phenylephrine eyedrops in order to achieve a proper dilation in premature infants undergoing screening for retinopathy of prematurity." | 3.85 | Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone. ( Barjol, A; Degoumois, A; Denion, E; Lux, AL; Mouriaux, F, 2017) |
| " Two cases of necrotizing enterocolitis could be ascribed to the use of tropicamide with a doubtful and plausible intrinsic imputability according to French imputability criteria." | 3.81 | [Serious adverse side effects after pupillary dilation in preterm infants]. ( Denion, E; Fedrizzi, S; Guillois, B; Lux, AL; Mouriaux, F; Peyro-Saint-Paul, L, 2015) |
| " After pupil dilation with 1 % tropicamide and 10 % phenylephrine for retinal examination, acute elevation of intraocular pressure (IOP) was observed in the right eye." | 3.81 | Acute angle-closure glaucoma in retinopathy of prematurity following pupil dilation. ( Chang, SH; Lee, YS; Wu, SC; Wu, WC, 2015) |
| "To observe and compare the effects of pupil dilation between Mydrin-P and compound tropicamide in the screening of retinopathy of prematurity." | 3.80 | Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity. ( Lu, Y; Luo, S; Wan, Z; Ye, Z; Yin, X, 2014) |
| " Here, two cases are presented in which we observed skin pallor around the eyes after instillation of phenylephrine 2." | 3.76 | The local vasoconstriction of infant's skin following instillation of mydriatic eye drops. ( Alpay, A; Battal, F; Ermis, B; Sagdik, HM; Ugurbas, SC, 2010) |
| " Otherwise, adverse events did not differ after either administration technique." | 3.11 | Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial. ( Diamanti, E; Georgiou, E; Haidich, AB; Lithoxopoulou, M; Mataftsi, A; Seliniotaki, AK; Talimtzi, P; Ziakas, N, 2022) |
| "To evaluate systemic adverse events after screening for retinopathy of prematurity (ROP) performed with mydriatic." | 1.62 | Systemic adverse events after screening of retinopathy of prematurity with mydriatic. ( Imamura, T; Kakinoki, M; Maruo, Y; Obata, S; Ohji, M; Yanagi, T, 2021) |
| "5% drop is effective and safe as mydriatic combination for retinopathy of prematurity screening." | 1.51 | Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study. ( Alpay, A; Aydemir, C; Canturk Ugurbas, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Obata, S | 1 |
| Imamura, T | 1 |
| Kakinoki, M | 1 |
| Yanagi, T | 1 |
| Maruo, Y | 1 |
| Ohji, M | 1 |
| Seliniotaki, AK | 2 |
| Lithoxopoulou, M | 2 |
| Talimtzi, P | 1 |
| Georgiou, E | 1 |
| Diamanti, E | 1 |
| Ziakas, N | 2 |
| Haidich, AB | 1 |
| Mataftsi, A | 2 |
| Alpay, A | 2 |
| Canturk Ugurbas, S | 1 |
| Aydemir, C | 1 |
| Mimori, K | 1 |
| Haneda, K | 1 |
| Shimizu, H | 1 |
| Yamashita, M | 1 |
| Tanaka, H | 1 |
| Prousali, E | 1 |
| Kokkali, S | 1 |
| Soubasi, V | 1 |
| Bembich, S | 1 |
| Demarini, S | 1 |
| Cont, G | 1 |
| Di Giusto, A | 1 |
| Mazzolai, M | 1 |
| Barbi, E | 1 |
| Risso, FM | 1 |
| Degirmencioglu, H | 1 |
| Oncel, MY | 1 |
| Calisici, E | 1 |
| Say, B | 1 |
| Uras, N | 1 |
| Dilmen, U | 1 |
| Lux, AL | 2 |
| Mouriaux, F | 2 |
| Guillois, B | 1 |
| Fedrizzi, S | 1 |
| Peyro-Saint-Paul, L | 1 |
| Denion, E | 2 |
| Luo, S | 1 |
| Wan, Z | 1 |
| Yin, X | 1 |
| Ye, Z | 1 |
| Lu, Y | 1 |
| Wu, SC | 1 |
| Lee, YS | 1 |
| Wu, WC | 1 |
| Chang, SH | 1 |
| Agrawal, Y | 1 |
| Patri, S | 1 |
| Kalavakunta, JK | 1 |
| Gupta, V | 1 |
| Degoumois, A | 1 |
| Barjol, A | 1 |
| Ermis, B | 1 |
| Ugurbas, SC | 1 |
| Battal, F | 1 |
| Sagdik, HM | 1 |
| Phamonvaechavan, P | 1 |
| Chutasmit, K | 1 |
| Damrongrak, P | 1 |
| Koukiatkul, S | 1 |
| Wongkiatkajorn, T | 1 |
| Ngerncham, S | 1 |
| Cohen, AM | 1 |
| Cook, N | 1 |
| Harris, MC | 1 |
| Ying, GS | 1 |
| Binenbaum, G | 1 |
| Rush, R | 1 |
| Rush, S | 1 |
| Nicolau, J | 1 |
| Chapman, K | 1 |
| Naqvi, M | 1 |
| Isenberg, S | 1 |
| Everett, S | 1 |
| Parelhoff, E | 1 |
| Berman, DH | 1 |
| Deutsch, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial[NCT04623684] | Phase 4 | 25 participants (Actual) | Interventional | 2020-03-24 | Completed | ||
| Efficiency and Safety of Phenylephrine and Tropicamide Used in Premature Retinopathy[NCT03448640] | 60 participants (Actual) | Observational | 2016-01-15 | Completed | |||
| Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening: a Non-inferiority Crossover Randomized Controlled Trial (MyMiROPS Trial)[NCT05043077] | Phase 4 | 83 participants (Actual) | Interventional | 2021-09-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tropicamide and Retrolental Fibroplasia
| Article | Year |
|---|---|
Alternative mydriasis techniques for retinopathy of prematurity screening.
Topics: Humans; Infant; Infant, Newborn; Infant, Premature; Mydriasis; Mydriatics; Ophthalmic Solutions; Phe | 2020 |
Alternative mydriasis techniques for retinopathy of prematurity screening.
Topics: Humans; Infant; Infant, Newborn; Infant, Premature; Mydriasis; Mydriatics; Ophthalmic Solutions; Phe | 2020 |
Alternative mydriasis techniques for retinopathy of prematurity screening.
Topics: Humans; Infant; Infant, Newborn; Infant, Premature; Mydriasis; Mydriatics; Ophthalmic Solutions; Phe | 2020 |
Alternative mydriasis techniques for retinopathy of prematurity screening.
Topics: Humans; Infant; Infant, Newborn; Infant, Premature; Mydriasis; Mydriatics; Ophthalmic Solutions; Phe | 2020 |
2 trials available for tropicamide and Retrolental Fibroplasia
| Article | Year |
|---|---|
Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial.
Topics: Heart Rate; Humans; Infant; Infant, Newborn; Infant, Premature; Mydriatics; Ophthalmic Solutions; Ph | 2022 |
Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants.
Topics: Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; I | 2012 |
15 other studies available for tropicamide and Retrolental Fibroplasia
| Article | Year |
|---|---|
Systemic adverse events after screening of retinopathy of prematurity with mydriatic.
Topics: Body Weight; Drug-Related Side Effects and Adverse Reactions; Female; Gestational Age; Humans; Infan | 2021 |
Efficiency and safety of phenylephrine and tropicamide used in premature retinopathy: a prospective observational study.
Topics: Blood Pressure; Drug Therapy, Combination; Gestational Age; Humans; Infant, Newborn; Infant, Prematu | 2019 |
Necrotizing enterocolitis after an eye examination with mydriatics.
Topics: Constriction, Pathologic; Drug Combinations; Enterocolitis, Necrotizing; Humans; Infant, Extremely L | 2020 |
Effect of mydriatic administration on cerebral haemodynamics and oxygenation in preterm infants.
Topics: Administration, Ophthalmic; Brain; Cerebrovascular Circulation; Drug Combinations; Female; Gestation | 2020 |
Transient ileus associated with the use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant.
Topics: Adult; Drug Combinations; Female; Gestational Age; Humans; Ileus; Infant, Newborn; Infant, Very Low | 2014 |
[Serious adverse side effects after pupillary dilation in preterm infants].
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enterocol | 2015 |
Comparison of the mydriatic effects of mydrin-P and compound tropicamide in the screening of retinopathy of prematurity.
Topics: Humans; Infant, Newborn; Infant, Premature; Mydriasis; Mydriatics; Ophthalmic Solutions; Pupil; Reti | 2014 |
Acute angle-closure glaucoma in retinopathy of prematurity following pupil dilation.
Topics: Acute Disease; Child, Preschool; Drug Combinations; Female; Glaucoma, Angle-Closure; Humans; Intraoc | 2015 |
Retinopathy of prematurity screening leading to cardiopulmonary arrest: fatal complication of a benign procedure.
Topics: Female; Heart Arrest; Humans; Infant; Mydriatics; Ophthalmic Solutions; Phenylephrine; Retinopathy o | 2016 |
Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up | 2017 |
The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.
Topics: Humans; Infant, Newborn; Infant, Premature; Mydriatics; Ophthalmic Solutions; Pallor; Phenylephrine; | 2010 |
The pain response to mydriatic eyedrops in preterm infants.
Topics: Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Mydriatics; Ophthalmic Soluti | 2013 |
Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity.
Topics: Administration, Topical; Anesthetics, Local; Drug Administration Schedule; Eyelids; Humans; Infant, | 2004 |
A comparison of mydriatic eyedrops in low-weight infants.
Topics: Blood Pressure; Cyclopentolate; Drug Combinations; Humans; Infant, Low Birth Weight; Infant, Newborn | 1984 |
Bilateral spontaneous pigment epithelial detachments in a premature neonate.
Topics: Fundus Oculi; Humans; Infant, Newborn; Infant, Premature, Diseases; Phenylephrine; Pigment Epitheliu | 1994 |